Antimicrobials Agents: Latest Advances and Prospects
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 5171
Interests: new antimicrobials; microbial metabolites; microbial interactions
Special Issues, Collections and Topics in MDPI journals
Antimicrobial resistance is considered by the World Health Organization to be one of the 10 global public health menaces facing humanity today, with serious medical, social and economic impacts. New data from 2022 studies estimate around 5 million deaths associated with antibiotic-resistant bacteria each year. More and more patients with infections caused by multidrug resistance pathogens no longer respond to available treatments. In addition, the antimicrobial pipeline has dried out, with less and less new antibiotics available on the market. Therefore, finding new innovative and effective solutions to keep the pace with the antibiotic resistance developed by microbial pathogens is particularly challenging and represents an important objective of current biomedical research.
In this Special Issue, we welcome the submission of publications on the most recent research in the discovery of new antimicrobials and strategies used to fight antimicrobial resistance. We invite authors to publish their original findings in this Antibiotics Special Issue entitled “Antimicrobials Agents: Latest Advances and Prospects”.
This Special Issue will provide new insights on the discovery of new antimicrobials and strategies used to fight antimicrobial resistance; in this way, fitting into the scope of Antibiotics (advances in research on new antibiotics; antibiotic resistance; qualitative and quantitative research exploring the determinants of antimicrobial use and resistance).
Dr. Marius Stefan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- multidrug-resistant pathogens
- infectious diseases
- antibiotic resistance
- new antimicrobials
- drug development
- antimicrobial activity
- structure–activity relationship (SAR)
- antimicrobial therapy